In vitro and in vivo studies have shown that PESVs are able to enhance the activity of hepatic NK cells by regulating the NKG2D-MICA pathway and inducing more cytotoxic granules to kill tumor cells, this promising therapeutic strategy can be applied to treat hepatic carcinoma. Here, KLRK1 is linked to hepatocellular carcinoma.